The Medigen Vaccine Biologics Corporation (MVC; traditional Chinese: 高端疫苗生物製劑; simplified Chinese: 高端疫苗生物制剂; pinyin: Gāoduān Yìmiáo Shēngwù Zhìjì) is a pharmaceutical company headquartered in Neihu, Taipei, Taiwan.
.jpg) | |
Native name | 高端疫苗生物製劑 |
|---|---|
| Founded | October 2012 |
| Headquarters | Neihu, Taipei, Taiwan |
| Parent | Medigen Biotechnology Corporation |
| Website | Official website |
History
editThe company was founded in October 2012.[1] During the COVID-19 pandemic in Taiwan, the company produces the MVC COVID-19 vaccine to fight the virus.[2]
Manufacturing plant
editThe company has a manufacturing plant in Hsinchu Biomedical Science Park, Zhubei City, Hsinchu County.[3]
See also
editReferences
edit- ^ "Vaccine". Medigen Biotechnology Corp. Archived from the original on 8 October 2021. Retrieved 8 October 2021.
- ^ Wang, Cindy; Ellis, Samson (6 September 2021). "Vaccine Minnow Medigen Targets Taiwan's Allies for Growth". Bloomberg. Archived from the original on 8 October 2021. Retrieved 8 October 2021.
- ^ "Contact Information". Medigen Vaccine Biologics Corp. Archived from the original on 7 October 2021. Retrieved 8 October 2021.
External links
edit
Wikimedia Commons has media related to Medigen Vaccine Biologics Corporation.
  | This article about a Taiwanese corporation or company is a stub. You can help Wikipedia by expanding it. |